NCT02977780 2025-11-10INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)Dana-Farber Cancer InstitutePhase 2 Recruiting460 enrolled
NCT02981940 2025-09-02A Study of Abemaciclib in Recurrent GlioblastomaDana-Farber Cancer InstitutePhase 2 Active not recruiting45 enrolled 10 charts
NCT04118036 2025-08-11Abemaciclib + Pembrolizumab In GlioblastomaDana-Farber Cancer InstitutePhase 2 Withdrawn